review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Yvette van Kooyk | Q29914012 |
P2093 | author name string | Ernesto Rodríguez | |
Joyce Lübbers | |||
P2860 | cites work | Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes | Q22010812 |
Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells | Q22010987 | ||
Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways | Q22254056 | ||
Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin | Q24303353 | ||
Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms | Q24561895 | ||
Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils | Q24651513 | ||
Properties and distribution of a lectin-like hemagglutinin differentially expressed by murine stromal tissue macrophages | Q24682747 | ||
Role of Trypanosoma cruzi Trans-sialidase on the Escape from Host Immune Surveillance | Q26752320 | ||
Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications | Q26764855 | ||
Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides | Q27318429 | ||
Pathogen recognition and innate immunity | Q27861084 | ||
C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB | Q28115656 | ||
Siglecs--the major subfamily of I-type lectins | Q28261393 | ||
Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury | Q28271835 | ||
Siglecs and their roles in the immune system | Q28294469 | ||
The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells | Q28294502 | ||
Siglec-15: an immune system Siglec conserved throughout vertebrate evolution | Q28300768 | ||
Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells | Q28511565 | ||
In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia | Q28554677 | ||
Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9 | Q39640710 | ||
Mucin-induced apoptosis of monocyte-derived dendritic cells during maturation | Q39952413 | ||
SIGLEC16 encodes a DAP12-associated receptor expressed in macrophages that evolved from its inhibitory counterpart SIGLEC11 and has functional and non-functional alleles in humans | Q39961007 | ||
Differentiation of human monocytes and derived subsets of macrophages and dendritic cells by the HLDA10 monoclonal antibody panel. | Q39979829 | ||
Phosphorylated ITIMs enable ubiquitylation of an inhibitory cell surface receptor | Q40038804 | ||
Siglec-1-positive plasmacytoid dendritic cells (pDCs) in human peripheral blood: A semi-mature and myeloid-like subset imbalanced during protective and autoimmune responses | Q40126744 | ||
Antigen targeting reveals splenic CD169+ macrophages as promoters of germinal center B-cell responses | Q40593868 | ||
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia | Q40705613 | ||
Comparative phenotypic and functional analysis of migratory dendritic cell subsets from human oral mucosa and skin | Q41006628 | ||
Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation. | Q41019222 | ||
Porcine arterivirus infection of alveolar macrophages is mediated by sialic acid on the virus | Q41039153 | ||
Targeted delivery of a sialic acid-blocking glycomimetic to cancer cells inhibits metastatic spread | Q41552892 | ||
CD22-antagonists with nanomolar potency: the synergistic effect of hydrophobic groups at C-2 and C-9 of sialic acid scaffold | Q41791550 | ||
The human sialyltransferase family | Q28619925 | ||
IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors | Q29618425 | ||
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia | Q29620607 | ||
Macrophage activation and polarization: nomenclature and experimental guidelines | Q29620642 | ||
Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses | Q30367426 | ||
Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells | Q30669536 | ||
Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes. | Q30868758 | ||
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study | Q33400617 | ||
Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells | Q33591529 | ||
Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus | Q33702945 | ||
Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses | Q33809905 | ||
Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. | Q33902330 | ||
Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells | Q33998442 | ||
Role of macrophage sialoadhesin in host defense against the sialylated pathogen group B Streptococcus | Q34048508 | ||
Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1. | Q34208916 | ||
Siglec-mediated regulation of immune cell function in disease. | Q34314957 | ||
Polymorphisms in the sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) gene are associated with susceptibility to asthma | Q34329191 | ||
Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. | Q34527437 | ||
Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins | Q34623034 | ||
Abandoning M1/M2 for a Network Model of Macrophage Function | Q34677978 | ||
Effects of beta-glucans on the immune system. | Q34693271 | ||
Signalling through C-type lectin receptors: shaping immune responses | Q34986405 | ||
Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia. | Q35146288 | ||
Involvement of sialoadhesin in entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages | Q35155052 | ||
Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation | Q35164415 | ||
The role of lung epithelial ligands for Siglec-8 and Siglec-F in eosinophilic inflammation. | Q35222976 | ||
Transforming growth factor beta 1 up-regulates CD169 (sialoadhesin) expression on monocyte-derived dendritic cells: role in HIV sexual transmission. | Q42182673 | ||
Dasatinib enhances migration of monocyte-derived dendritic cells by reducing phosphorylation of inhibitory immune receptors Siglec-9 and Siglec-3. | Q42215521 | ||
Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome | Q42321222 | ||
Aberrant sialylation of a prostate-specific antigen: Electrochemical label-free glycoprofiling in prostate cancer serum samples | Q42615371 | ||
Evolution of sialic acid-binding proteins: molecular cloning and expression of fish siglec-4. | Q44960266 | ||
Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling | Q45186177 | ||
Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy | Q46084072 | ||
Exploiting CD22 on antigen-specific B cells to prevent allergy to the major peanut allergen Ara h 2. | Q47146910 | ||
High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization. | Q47314216 | ||
Immunophenotypic and functional characterization of cord blood dendritic cells | Q47805839 | ||
DC-SIGN reacts with TLR-4 and regulates inflammatory cytokine expression via NF-κB activation in renal tubular epithelial cells during acute renal injury. | Q47817260 | ||
Blood monocytes sample MelanA/MART1 antigen for long-lasting cross-presentation to CD8+ T cells after differentiation into dendritic cells | Q47836358 | ||
CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti-CD22 antibodies to peripheral blood dendritic cells | Q47972490 | ||
The tumour glyco-code as a novel immune checkpoint for immunotherapy | Q49339093 | ||
Systems immunology allows a new view on human dendritic cells | Q49968569 | ||
Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8+ T Cell Cross-Priming | Q50098041 | ||
Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer | Q50138794 | ||
Epratuzumab for the treatment of systemic lupus erythematosus. | Q51762950 | ||
Differential regulation of C-type lectin expression on tolerogenic dendritic cell subsets. | Q51804743 | ||
Glycosylation of Human IgA Directly Inhibits Influenza A and Other Sialic-Acid-Binding Viruses. | Q52332235 | ||
Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses. | Q55004069 | ||
Serum sialylation changes in cancer. | Q55410162 | ||
Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway. | Q55453765 | ||
CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover | Q61937663 | ||
Intravenous immunoglobulin preparations contain anti–Siglec-8 autoantibodies | Q61959765 | ||
Biophysical analysis of sialic acid recognition by the complement regulator Factor H. | Q64981056 | ||
Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells | Q71651093 | ||
An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas | Q73182063 | ||
Negative regulation of leucocyte functions by CD33-related siglecs | Q79316011 | ||
High-affinity ligand probes of CD22 overcome the threshold set by cis ligands to allow for binding, endocytosis, and killing of B cells | Q80142470 | ||
Human peripheral blood dendritic cells and monocyte subsets display similar chemokine receptor expression profiles with differential migratory responses | Q80379325 | ||
Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells | Q80853556 | ||
The C-type lectin macrophage galactose-type lectin impedes migration of immature APCs | Q81803363 | ||
The origin and function of tumor-associated macrophages | Q85309668 | ||
Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial | Q87159616 | ||
Constitutively expressed Siglec-9 inhibits LPS-induced CCR7, but enhances IL-4-induced CD200R expression in human macrophages | Q87386205 | ||
Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKKε- and CYLD-dependent Bcl3 activation | Q87966506 | ||
Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell-Mediated Tumor Immunity | Q88497824 | ||
Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins | Q88641670 | ||
Characterization of Siglec-8 Expression on Lavage Cells after Segmental Lung Allergen Challenge | Q89027053 | ||
Selective Inhibition of Sialic Acid-Based Molecular Mimicry in Haemophilus influenzae Abrogates Serum Resistance | Q89460922 | ||
Proliferating dendritic cell progenitors in human blood | Q36363279 | ||
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells | Q36742670 | ||
Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells | Q36962406 | ||
Glycobiology simplified: diverse roles of glycan recognition in inflammation | Q37111287 | ||
Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. | Q37133445 | ||
Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response | Q37151185 | ||
Precision glycocalyx editing as a strategy for cancer immunotherapy. | Q37264064 | ||
Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. | Q37292766 | ||
Siglecs as positive and negative regulators of the immune system | Q37330497 | ||
The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. | Q37600827 | ||
The sialome--far more than the sum of its parts | Q37781367 | ||
Evolutionary forces shaping the Golgi glycosylation machinery: why cell surface glycans are universal to living cells | Q37869710 | ||
Human dendritic cell subsets | Q38101992 | ||
Monocytes and macrophages: developmental pathways and tissue homeostasis | Q38214042 | ||
Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules. | Q38296552 | ||
Decoration of Histophilus somni lipooligosaccharide with N-acetyl-5-neuraminic acid enhances bacterial binding of complement factor H and resistance to killing by serum and polymorphonuclear leukocytes | Q38322923 | ||
Dendritic cells and monocyte-derived cells: Two complementary and integrated functional systems | Q38468896 | ||
Human mononuclear phagocyte system reunited. | Q38488997 | ||
Reduced expression of E-cadherin and increased sialylation level in clear cell renal cell carcinoma | Q38652014 | ||
Encapsulating an Immunosuppressant Enhances Tolerance Induction by Siglec-Engaging Tolerogenic Liposomes | Q38754057 | ||
Sialic Acid Mimetics to Target the Sialic Acid-Siglec Axis | Q38809923 | ||
Siglec-9 modulated IL-4 responses in the macrophage cell line RAW264. | Q38821814 | ||
Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigen | Q38848780 | ||
C-type lectin receptors in the control of T helper cell differentiation | Q38862647 | ||
Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E). | Q38994497 | ||
Discovery of multifold modified sialosides as human CD22/Siglec-2 ligands with nanomolar activity on B-cells | Q38997270 | ||
Paired Siglec receptors generate opposite inflammatory responses to a human-specific pathogen. | Q39013799 | ||
Sialic acids in squamous cell carcinoma of the head and neck. | Q39094176 | ||
The lectin self of complement factor H. | Q39131894 | ||
Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation. | Q39164482 | ||
Myeloid C-Type Lectin Receptors in Viral Recognition and Antiviral Immunity | Q39192653 | ||
Sialoglycoproteins adsorbed by Pseudomonas aeruginosa facilitate their survival by impeding neutrophil extracellular trap through siglec-9. | Q39412913 | ||
The Interplay between the Host Receptor and Influenza Virus Hemagglutinin and Neuraminidase | Q39438794 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | carboxylic acid | Q134856 |
glycoprotein | Q187126 | ||
cell | Q7868 | ||
lectin | Q408693 | ||
carbohydrate | Q11358 | ||
immune tolerance | Q1356761 | ||
hemic and immune systems | Q70202933 | ||
P304 | page(s) | 2807 | |
P577 | publication date | 2018-01-01 | |
2018-12-07 | |||
P1433 | published in | Frontiers in Immunology | Q27723748 |
P1476 | title | Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions | |
P478 | volume | 9 |
Q92345552 | CROI 2019: neurologic complications of HIV disease |
Q64386928 | Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing |
Q92865495 | Evaluation of CD33 as a genetic risk factor for Alzheimer's disease |
Q89531656 | Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin |
Q93135675 | Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells |
Q90455147 | Going Native: Synthesis of Glycoproteins and Glycopeptides via Native Linkages To Study Glycan-Specific Roles in the Immune System |
Q90261156 | Identification of lipophilic ligands of Siglec5 and -14 that modulate innate immune responses |
Q90482381 | Mucins and their receptors in chronic lung disease |
Q89965774 | NK Cell-Based Immune Checkpoint Inhibition |
Q92778325 | Production, purification and characterization of recombinant human R-spondin1 (RSPO1) protein stably expressed in human HEK293 cells |
Q90216632 | Role of CCR7 on dendritic cell‑mediated immune tolerance in the airways of allergy‑induced asthmatic rats |
Q90107123 | Sialic acid metabolism as a potential therapeutic target of atherosclerosis |
Q104503342 | Sialylation acts as a checkpoint for innate immune responses in the central nervous system |
Q92261709 | Subcutaneous immunotherapy using modified Phl p5a-derived peptides efficiently alleviates allergic asthma in mice |
Q98513850 | Targeted glycan degradation potentiates the anticancer immune response in vivo |
Q92734884 | Trophoblast cell differentiation in the bovine placenta: differentially expressed genes between uninucleate trophoblast cells and trophoblast giant cells are involved in the composition and remodeling of the extracellular matrix and O-glycan biosynt |
Q100694175 | Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19 |
Search more.